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The innate immune system faces the difficult task of keeping a fine balance between sen-
sitive detection of microbial presence and avoidance of autoimmunity. To this aim, key
mechanisms of innate responses rely on isolation of pathogens in specialized subcellular
compartments, or sensing of specific microbial patterns absent from the host. Efficient
detection of foreign RNA in the cytosol requires an additional layer of complexity from the
immune system. In this particular case, innate sensors should be able to distinguish self
and non-self molecules that share several similar properties. In this review, we discuss
this interplay between cytosolic pattern recognition receptors and the microbial RNA they
detect. We describe how microbial RNAs gain access to the cytosol, which receptors they
activate and counter-strategies developed by microorganisms to avoid this response.
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INTRODUCTION
When Janeway formulated the theory of pattern recognition in
1989, he proposed that host cells could sense microbial infection
owing to receptors able to recognize invariant molecular struc-
tures defined as pathogen-associated molecular patterns (PAMPs).
These patterns would be present in groups of pathogens,but absent
in the host (1). Years later, Janeway and Medzhitov described
the activity of the first mammalian member of the Toll-like
receptor (TLR) family, Toll-like receptor 4 (2). TLRs comprise
a family of transmembrane proteins able to recognize conserved
microbial features and activate the immune response (3). Once
activated, TLRs and others pattern recognition receptors (PRRs)
initiate several intracellular pathways, including those mediated
by nuclear factor-κB (NF-κB), mitogen-activated protein kinases
(MAPKs), and interferon regulatory factors (IRFs). Another out-
come of activation of distinct members of cytosolic PRRs is
their oligomerization into multimeric cytosolic structures called
inflammasomes, which activate the cysteine protease caspase-1,
subsequently leading to the production of biologically active forms
of pro-inflammatory cytokines (4).
Initially thought to detect exclusively microbial derived ligands,
PRRs were later shown to recognize host derived danger signals,
which are released in response to stress conditions such as cellular
damage or tissue injury (3). Under normal physiological condi-
tions, these ligands are not accessible to their respective PRRs and
do not activate the immune system. Conversely, it was first sug-
gested that self-DNA artificially introduced into the cytoplasm by
transfection could activate NF-κB and the MAPK pathway (5).
Evidence that any DNA, regardless of its origin, can engage innate
immune receptors when localized outside of the nucleus was fur-
ther confirmed by the identification of several endosomal and
cytosolic DNA sensors [reviewed in Ref. (6)].
In contrast to cytosolic DNA, RNA sensing in the cytoplasm
raises many questions on the mechanisms used by the innate
system to specifically distinguish non-self-RNA from self-RNA.
During infection, microbial RNAs share the cytosolic cellular com-
partment with several host RNA species, including messenger
RNA (mRNA), transfer RNA (tRNA), ribosomal RNA (rRNA),
microRNA, and other small regulatory RNAs. As a consequence,
cytosolic sensors must display a high affinity for specific microbial
features to avoid activation by host molecules that would other-
wise elicit autoimmune responses. Despite this apparent challenge,
efficient detection of foreign RNA in the cytosol is essential for
innate immunity. During certain viral infections, RNA may be
the only microbial PAMP produced throughout most of the repli-
cation cycle. Additionally, our laboratory previously showed that
recognition of bacterial mRNA in the cytosol was critical to elicit
a robust innate response against bacterial infection (7). Finally,
cytosolic sensing of pathogen invasion by non-immune infected
cells provides the very first steps of innate response against infec-
tion, before phagocytosis-competent immune cells are recruited
to the site of infection.
In this review, we summarize the current understanding of
cytosolic RNA sensing. We describe instances in which microbial
RNAs gain access to the cytosol, the PRRs they activate, their cor-
responding ligands and strategies developed by microorganisms
to conceal their RNAs.
RNA ACCESS TO THE CYTOSOL
RNA entry into host cells generally takes place during the first steps
of a microbial infection. We distinguish four processes leading to
the presence of microbial RNA in the cytosol of eukaryotic cells,
where it can engage host PRRs (Figure 1).
RELEASE OF THE VIRAL GENOME AND TRANSCRIPTION OF
REPLICATION INTERMEDIATES
A first process, observed during RNA virus infection, consists
of viral genome release into the cytosol during the cell entry
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FIGURE 1 | Cytosolic recognition of microbial RNA. Genomic RNA
from RNA viruses access the cytosol immediately after the cell entry
step of the replication cycle, where it may be amplified by viral
RNA-dependent RNA polymerase (RdRp). Genomic DNA from DNA
viruses is transcribed by viral or cellular RNA polymerase, including the
cytosolic RNA polymerase III. Bacterial RNA can access the cytosol
through the activity of auxiliary secretion systems or during passive
leakage of phagosomal products. Once in the cytosol, microbial RNA
binds different families of PRRs classified as RLRs, non-RLR helicases,
and other receptors. Downstream signaling pathways include activation
of MAVS, TRIF, and the NLRP3 inflammasome. Black arrows, RNA entry;
red arrows, signaling pathways.
step of the replication cycle. Viruses can directly release their
genome at the plasma membrane after binding to a recep-
tor. Alternatively, they can be first internalized through endo-
cytosis or macropinocytosis. Endocytosed virus particles will
typically traffic through endosomal vesicles by actin-dependent
and/or microtubule-dependent transport (8). Specific environ-
mental triggers like endosomal pH acidification induce either
fusion of enveloped virus with the endosome, or membrane
penetration of viral proteins, allowing viral genetic material
to be released into the cytoplasm (8). Alternatively, viruses
can spread by direct cell–cell contact (9). Cell-to-cell trans-
mission of viral material can activate cytoplasmic innate path-
ways, as exemplified with hepatitis C virus (10), lymphocytic
choriomeningitis virus (11), or human immunodeficiency virus
transmission (12).
Other viral RNA PAMPs can be produced during viral repli-
cation. David Baltimore has defined a classification of viruses
based on the mechanism of mRNA production (13). Viruses are
clustered in seven groups depending on their genomes (DNA,
RNA), strandedness (single or double), sense or antisense, and
method of replication. The type of RNA ligands produced dur-
ing viral replication will depend on the type of viral genome
and the strategy used to generate mRNA. RNA ligands can be
generated by DNA viruses and retroviruses via genome tran-
scription, or by synthesis of mRNA and replication interme-
diates by RNA-dependent RNA polymerases (RdRps) of RNA
viruses (8).
PHAGOSOMAL LEAKAGE OF MICROBIAL LIGANDS
It has been shown that ligands generated in phagolysosomes after
phagocytosis of bacteria by immune cells can engage cytoso-
lic innate immune receptors (14). Similarly, we showed that
RNA from Escherichia coli could activate receptors in the cytosol
after phagocytosis by macrophages (7). We demonstrated that
phagosomes carrying E. coli exhibit intrinsic leakiness, sug-
gesting a mechanism by which bacterial RNA, irrespective of
the activity of virulence factors, can gain access to the cyto-
plasm (7).
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ACTIVE TRANSLOCATION OF BACTERIAL RNA TO THE CYTOPLASM
Alternatively, bacteria express secretion systems to translocate
products outside of the bacterial cell wall. In the case of
intracellular bacteria, auxiliary secretion systems like SecA2 in
Listeria monocytogenes have been shown to actively translocate
Listeria RNA into the cytoplasm, resulting in activation of cytoso-
lic sensors (15, 16). Similarly, another study proved that cytosolic
RNA sensors participate in the type 1 interferon (IFN-I) response
to Legionella pneumophila. Although the authors did not demon-
strate the translocation of Legionella RNA into the cytosol of
infected cells, they discuss their data through a model where it
would be the case (17). Future studies looking for additional
secreted RNA will likely provide additional insights on their
interaction with the innate immune system.
ACTIVITY OF RNA POLYMERASE III
Two independent groups have demonstrated that cytoplasmic
dsDNA triggers IFN-I production via RNA polymerase III, which
transcribes DNA into 5’-triphosphate (5′-ppp) RNA, subsequently
recognized by cytosolic RNA receptors (18, 19). This pathway
has been involved in the sensing of DNA viruses, like Epstein–
Barr virus, or intracellular bacteria, like L. pneumophila (18, 19).
Although the RNA intermediate produced is not sensu stricto
microbial, its generation is due to the activity of a microbial
invader.
KNOWN CYTOSOLIC RNA SENSORS AND THEIR LIGANDS
The best-studied cytosolic RNA sensors are the three members
of RIG-I-like Receptors (RLRs), a subfamily of the DExD/H-
box family of helicases. They consist of retinoic acid-inducible
gene I (RIG-I), melanoma differentiation factor 5 (MDA5), and
laboratory of genetics and physiology 2 (LGP2). They share a sim-
ilar organization with three distinct domains: (i) a C-terminal
repressor domain (RD) embedded within the C-terminal domain
(CTD); (ii) a central ATPase containing DExD/H-box helicase
domain able to bind RNA; and (iii) a N-terminal tandem CARD
domain that mediates downstream signaling, and which is present
in RIG-I and MDA5 but absent in LGP2. Upon activation by
RNA ligands, RIG-I and MDA5 are subsequently recruited to the
adaptor protein Mitochondrial Antiviral Signaling (MAVS) via a
CARD–CARD interaction and lead to activation of NF-κB and
IRFs (20–23). In contrast to TLR expression that is predominantly
expressed in specialized immune cells such as macrophages and
dendritic cells (DCs), RLRs are found in the cytosol of most cell
types and are strongly induced in response to IFN-I (24, 25).
RETINOIC ACID-INDUCIBLE GENE I
The RIG-I ligand has been characterized as an RNA molecule with
two distinct features: (i) a 5′-ppp moiety (26, 27) and (ii) blunt-
end base pair at the 5’-end (28, 29). Blunt-end base pairs can
be found in double-stranded RNA (dsRNA) and secondary RNA
structures such as hairpin or panhandle conformations (28, 29).
Recent structural studies have contributed toward a better under-
standing of ligand binding and activation of RIG-I. Specificity of
5′-ppp binding is conferred by the CTD, and the helicase domain
binds the double-stranded part of the RNA. RIG-I is normally held
in an auto-repressed conformation, and ligand binding results in
a conformational change, releasing the CARD domain which can
subsequently initiate signaling by association with MAVS (30–32).
Despite the increasing amount of high-resolution crystal data, the
consensus definition of RIG-I ligand remains controversial. Other
RIG-I ligands have been indeed described in the literature includ-
ing long (33) or short dsRNA (34–36) lacking the 5′-ppp. However,
thermodynamic analysis have shown that the full-length human
RIG-I protein binds 5’-ppp dsRNA with 126-fold higher affinity
than 5’-OH dsRNA, and dsRNA with a 361-fold higher affin-
ity than short single stranded RNA (ssRNA) lacking secondary
structure (37).
Many viral families display blunt-end base-paired RNA with
a 5′-ppp, directly in their genomic RNA or in replication inter-
mediates. Consistent with this notion, RIG-I has been shown to
be involved in the recognition of many viruses, either antisense
(−)ssRNA viruses (38, 39) or sense (+)ssRNA/dsRNA viruses
(40, 41). Notably RIG-I can detect panhandle structures found in
LaCrosse viral particles (39) or in influenza genomic RNA (28, 38).
Sendai Virus (SeV) and other Mononegavirales produce defective
interfering (DI) viral genomes containing panhandle structures
that activate RIG-I in infected cells (42).
Retinoic acid-inducible gene I recognition has not been lim-
ited to RNA virus since RIG-I is involved in recognition of DNA
viruses, such as Epstein–Barr virus or adenovirus through the
RNA polymerase III pathway (18, 43, 44). Moreover, RIG-I is
also able to detect bacterial infections. Bacterial mRNA are not
capped and it has been estimated that approximately 40% of RNA
oligonucleotides in E. coli have a 5′-ppp (45). Reports in the liter-
ature describe sensing of L. monocytogenes secreted RNA (15, 16)
or purified Legionella (17) and Helicobacter pylori RNA (46) by
RIG-I. Finally, RIG-I can also sense Shigella flexneri infection in
macrophages through the RNA polymerase III pathway (47).
MELANOMA DIFFERENTIATION FACTOR 5
Melanoma differentiation factor 5 ligand is less characterized than
RIG-I. Using poly(I:C) as a synthetic dsRNA mimic, studies have
shown that MDA5 binds long, but not short dsRNA (35, 40, 48).
Structural analyses have demonstrated that MDA5 specifically rec-
ognizes the internal duplex structure of dsRNA and uses it as a
platform to stack along dsRNA in a head-to-tail arrangement. This
mechanism promotes stochastic assembly of the tandem CARD
oligomers that activates the signaling adaptor MAVS (49).
Melanoma differentiation factor 5 detects infection by viral
families known to produce long dsRNA structures during their
replication cycle, including (+)ssRNA viruses like picornaviruses,
dsRNA viruses like reoviruses, or DNA viruses like poxviruses (35,
50–53). In the case of (+)ssRNA virus infection, fluorescent imag-
ing studies have confirmed that MDA5 recognizes preferentially
the dsRNA generated during the replication of these viruses, but
not the genomic ssRNA (54).
Prior to the structural study mentioned above, multiple obser-
vations raised the possibility that there may exist additional MDA5
ligands, different from the consensus long dsRNA. Thus, a study
has shown that MDA5 cooperates with the ribonuclease RNase
L to induce IFN-I in response to a viral mRNA from parain-
fluenza 5 virus (55). Interestingly, RNase L converts RNA into
small RNA products, with shorter length than the current MDA5
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ligand definition (56). Another work published the same year has
shown that mRNA lacking 2’-O-methylation at their 5’ cap struc-
ture induces production of IFN-I through MDA5 activation (57).
However, the data published, which focus on coronavirus infec-
tion, did not elucidate whether the absence of methylation was
directly recognized by MDA5 or via another intermediate (57).
MAVS MEDIATES SIGNALING DOWNSTREAM OF RIG-I AND MDA5
After binding to their specific ligands, both RIG-I and MDA5 acti-
vate MAVS to trigger a common signaling pathway. The majority of
MAVS is localized on the mitochondrial membrane and its engage-
ment by RLRs causes a conformational change that propagates to
adjacent un-activated MAVS in a prion-like behavior (58). The
formation of these very large MAVS aggregates results in a large-
scale amplification of the signaling cascade. This cascade involves
the recruitment of cytosolic adaptor molecules, followed by the
activation of the canonical IKKs, IKK-α, IKK-β, and IKK-γ, the
MAPK and the non-canonical IKK-related kinase, TBK1 and IKK-
i/ε. Ultimately, specific transcription factors, such as IRF3, NF-κB,
and depending on the cell type IRF5 and IRF7, are translocated
to the nucleus where they promote the expression of IFN-I genes
and pro-inflammatory cytokines [reviewed in Ref. (59)].
Finally, MAVS has been recently shown to interact with NOD-
like receptor family, pyrin domain containing 3 (NLRP3) and
promote its recruitment to the mitochondria. The authors empha-
size the central role of MAVS in innate immune signaling events
by showing its importance in the functioning of NLRP3 inflam-
masome and the production of IL-1β (60). Of note, MAVS inde-
pendent activation of the NLRP3 inflammasome by RIG-I has also
been reported (61, 62).
LABORATORY OF GENETICS AND PHYSIOLOGY 2
The third member of RLRs, LGP2, is able to bind dsRNA (63, 64),
however, its role in immune activation is poorly understood. LGP2
was proposed to be a modulator of RLR signaling. Studies showed
that LGP2 was required for RIG-I and MDA5 activity, in particu-
lar during picornaviral infection (65–67). Another work proposed
that LGP2 would inhibit RIG-I through competition with its lig-
and (64). It is however unclear whether LGP2 binds microbial
RNA in an infectious context, and what specific features of the
RNA it would recognize. Further studies will be required to clarify
the precise role of LGP2.
NON-RLR HELICASES
Apart from RLR, several recent studies have highlighted the impor-
tance of other DExD/H-box helicases in microbial RNA sensing.
RNA helicases of the DEAD box family are involved in various
different steps of RNA metabolism [reviewed in Ref. (68)]. They
share eight conserved motifs that are involved in ATP binding,
ATP hydrolysis, nucleic acid binding, and RNA unwinding activ-
ity. Additionally, most DExD/H-box helicases contain auxiliary N-
and C-terminal domains that confer on them functional specifici-
ties, such as an ability to induce downstream signaling or to bind
specific RNA targets (69).
DDX3
DDX3 (DDX3X) can bind poly(I:C) or vesicular stomatitis virus
(VSV) RNA and was shown to enhance the IFN-I response to
VSV infection by interaction with the RLR-MAVS complex. Over-
expression assays suggest that DDX3 precipitates with RIG-I and
MDA5 (70). Since DDX3 is easily detected in resting cells, the
authors propose a sentinel role for this helicase, the activity of
which would be required during the initial steps of viral infection.
Another study showed that upon SeV infection, DDX3 interacts
with IKKε, an essential component of the IRF3 signaling pathway,
increasing the induction of the IFN-β promoter (71). Moreover,
DDX3 is targeted by vaccinia virus protein K7 (71), an inhibitor
of IFN-β production, and by HCV core protein, which can disrupt
its interaction with MAVS (72). These observations highlight the
importance of DDX3 in efficient viral sensing.
DHX9
Using overexpression and knock-down experiments, DHX9 was
shown to be required for the production of IFN-I and pro-
inflammatory cytokines in response to poly(I:C), influenza virus,
and reovirus by a murine splenic DC line and bone-marrow
derived DCs. DHX9 can bind dsRNA via its dsRNA-binding motif
and interact with MAVS through both its helicase C-terminal
domain and HA2-DUF (73).
DDX1, DDX21, AND DHX36
Myeloid DCs have also been shown to express a complex com-
posed of DDX1, DDX21, and DHX36 that triggers an antiviral
program in response to poly(I:C), in a pathway dependent of
the adapter molecule TIR-domain containing adapter-inducing
interferon-β (TRIF). DDX1 binds to poly(I:C) via its helicase A
domain, while DHX36 and DDX21 bind the TIR domain of TRIF
via their HA2-DUF and PRK domains, respectively. This complex
seems to be required for the innate response against influenza or
reovirus infection (74). Notably, a separate study also character-
ized DHX36 and DHX9 as a sensor for the dsDNA species CpG-A
and -B, respectively. In this case, both DHX36 and DHX9 acti-
vate the cytosolic adapter protein myeloid differentiation primary
response gene 88 (MyD88) by binding to its TIR domain (75).
DHX33
Another recent study by Yong-Jun Liu’s group identified another
helicase, DHX33, as a cytosolic RNA receptor able to activate the
NLRP3 inflammasome (76). DHX33 is involved in inflammasome
activation after sensing cytosolic RNA such as poly(I:C) or reoviral
RNA when directly delivered by lipofection to the cytoplasm of a
macrophage cell line or human monocyte-derived macrophages.
Additional experiments suggested that DHX33 could also possibly
be involved in detection of cytosolic bacterial RNA. The authors
showed that DHX33 can bind to dsRNA through its helicase C
domain and to NLPR3 through its DEAD domain (76). A few
months later, another study performed on myeloid DCs confirmed
the role of DHX33 in the sensing of cytosolic poly(I:C) and reovi-
ral RNA. Surprisingly, in this case, poly(I:C)-induced activation of
MAPK, NF-κB, and IRF3 was mediated by MAVS, which binds the
helicase C domain of DHX33 (77).
DDX60
DDX60 has also been shown to enhance the IFN-I response to
RNA and DNA stimulation through formation of complexes with
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RIG-I, MDA5, and LGP2 but not with MAVS. This complex for-
mation has been deciphered with overexpression assays in the case
of MDA5 and LGP2, and with endogenous RIG-I during VSV
infection. DDX60 expression is induced by viral infection and its
helicase domain can bind ds- or ss-VSV RNA generated in vitro,
independently of the 5′-ppp (78). Interestingly, DDX60 can also
bind dsDNA, and was shown to play role in IFN-I expression
after infection with Herpes Simplex Virus-1, a DNA virus. This
ability to bind both dsRNA and DNA raises the question of the
feature DDX60 recognizes. It should be finally noted that the role
of DDX60 in the IFN-I pathway has been questioned (79).
OTHER RNA RECEPTORS
Several other cytoplasmic receptors have been shown to play a role
in microbial RNA recognition. This is the case for the cytoplasmic
protein kinase R (PKR), which is important for antiviral activ-
ity. PKR is activated by dsRNA from viruses and is a component
of MAPK and NF-κB signaling pathways [reviewed in Ref. (80)].
Activation of PKR can also be mediated by short 5′-ppp RNAs
containing limited secondary structures (81).
Proteins from the Interferon-induced protein with tetratri-
copeptide repeats (IFITs) family, such as IFIT1 and 5, bind 5′-ppp
of viral RNA (82). Using short in vitro transcribed oligonu-
cleotides, crystal structure studies have demonstrated that IFIT
proteins contain a positively charged cavity designed to engage,
without any particular sequence specificity, ssRNA with a 5′-ppp
end. Contrary to RIG-I, IFIT proteins cannot bind blunt-ended
5′-ppp dsRNA, and owing to the limitations imposed by their
RNA-binding pockets, IFIT1 and IFIT5 require 5’-overhangs of at
least 5 or 3 nt, respectively (83).
Using a 2′-O-methyltransferase mutant of Japanese encephali-
tis virus, another study showed that IFIT1 preferentially binds to
5′ capped 2′-O-unmethylated mRNA (84), confirming previous
findings showing that 2′-O-methylation of viral mRNA caps pro-
motes IFIT1 evasion (85, 86). The mechanism of IFIT1 antiviral
action is not completely understood, and it has been proposed that
IFIT might sequester viral RNAs (82) or inhibit viral mRNA trans-
lation (84). The crystal structure of IFIT2 (known as ISG54) was
also described. IFIT2 specifically binds adenylate uridylate (AU)-
rich RNAs in vitro, independently of the presence of a 5′-ppp (87).
The authors showed that RNA-binding capacity of this protein
mediates its antiviral properties, using a model of HEK293T cells
infected by Newcastle disease virus or SeV (87).
Nucleotide-binding oligomerization domain containing pro-
tein 2 (NOD2) is a member of the NOD1/Apaf-1 family and
encodes a protein with two CARD domains and six leucine-
rich repeats (LRRs). NOD2 is primarily known for its ability
to recognize bacterial peptidoglycan, but it also plays a role in
the antiviral response. NOD2 has been shown to activate MAVS
after stimulation with viral ssRNA or human respiratory syncytial
virus infection (88). NLRP3 is involved in cytosolic RNA sensing.
Caspase-1 cleavage triggered by influenza virus, SeV, or bacterial
mRNA is dependent on NLRP3 inflammasome activation (7, 89,
90). However, direct binding of NOD2 or NLRP3 to microbial
RNA has not been established.
Leucine-rich repeat flightless-interacting protein 1 (LRRFIP1)
contributes to the production of IFN-β induced by VSV and
L. monocytogenes in macrophages (91). Mostly located in the
cytosol, LRRFIP1 can also be found in RNA-containing lyso-
somes (92). LRRFIP1 can bind both dsRNA and dsDNA and
subsequently induce IFN-I expression through β-catenin phos-
phorylation. Activated β-catenin is translocated to the nucleus and
increases IFN-β expression by binding to the C-terminal domain
of the transcription factor IRF3 and promoting the recruitment of
the acetyltransferase p300 to the Ifnb1 promoter.
IMMUNOSTIMULATORY FEATURES AND OTHER PUTATIVE
RNA PAMPs
Several other microbial RNA features have been suspected or
proposed to act as potential signals for cytosolic sensing, sug-
gesting the existence of receptors detecting these characteristics.
A computational analysis identified CpG motifs in an AU-rich
RNA as an immunostimulatory feature. This sequence motif is
underrepresented in both ssRNA viruses and host innate immune
gene mRNA, and its frequency in influenza virus genomes has
decreased throughout evolution (93). Since this evolutionary pres-
sure seems to also be applied on host mRNA, the implication
of a cytosolic receptor is possible, although experimental stud-
ies identified endosomal TLR7 as a potential PRR (94). Another
study identified the nucleotide bias of A-rich HIV-1 genome as a
strong inducer of IFN-I and potent mediator of lentiviral path-
ogenicity. The authors showed that the ability of RNA sequences
derived from the HIV-1 genome to induce an interferon response
correlated with their nucleotide bias and that codon-optimized
sequences lost their stimulatory activity (95). The experimental
procedure used in this study consisted of direct delivery via lipo-
fection of in vitro transcribed RNA sequences into the cytosol of a
reporter cell line, suggesting a potential role for a cytoplasmic RNA
sensor (95). Recently, our group identified bacterial mRNAs as an
activator of the NLRP3 inflammasome. Polyadenylation of these
RNAs abrogated their immunostimulatory activities, suggesting
that features at the 3′ end of mRNA, rather than the 5′ end, could
engage cytoplasmic cellular sensors (7).
Philip Bevilacqua’s group has shown that different nucle-
oside modifications on RNA, such as base or sugar internal
modifications, suppress their intrinsic ability to activate immune
sensors, notably PKR. The authors propose that self-RNA edit-
ing could be a mechanism used by the innate immune sys-
tem to discriminate self-transcripts from “unmodified” microbial
RNAs (96, 97). Conversely, microbial RNA editing by cellular
deaminase enzymes such as dsRNA-specific adenosine deaminase
(ADAR) have been shown to enhance its recognition by cytosolic
sensors (98).
Other host transcript specificities, like association to cellular
components that prevent PRR binding, or specific tertiary struc-
ture such as the eukaryotic mRNA closed loop conformation (99),
could be determinants for the differentiation of host mRNAs from
microbial RNAs. Identification of receptors able to recognize such
features are lacking so far.
MICROBIAL ESCAPE STRATEGIES
Infectious microorganisms have developed several strategies to
evade cytosolic sensing. One of these strategies, which we only
mention briefly here, is the direct targeting by microbial proteins
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Table 1 | Cytosolic RNA sensors and their ligands.
RNA sensor Proposed RNA ligand Families of reported recognized pathogens
RIG-I 5′-ppp with blunt-end base pairing ssRNA; dsRNA (−)ssRNA viruses, (+)ssRNA viruses, dsRNA viruses, bacteria.
DNA viruses, and bacterial DNA through polymerase III pathway
MDA5 Long dsRNA (−)ssRNA viruses, (+)ssRNA viruses, dsRNA viruses, DNA viruses
LGP2 dsRNA (+)ssRNA viruses
DDX3 Viral RNA; poly(I:C) (−)ssRNA viruses
DHX9 Viral RNA; poly(I:C) (−)ssRNA viruses, dsRNA viruses
DDX1, DDX21, and DHX36 Viral RNA; poly(I:C) (−)ssRNA viruses, dsRNA viruses
DHX33 Viral RNA; poly(I:C) dsRNA viruses, bacteria
DDX60 In vitro transcribed ssRNA and dsRNA (−)ssRNA viruses, DNA viruses
PKR dsRNA; short 5′-ppp RNA (−)ssRNA viruses, (+)ssRNA viruses, dsRNA viruses, DNA viruses
IFIT1 and IFIT5 5′-ppp ssRNA; 5′ capped 2′-O-unmethylated RNA (−)ssRNA viruses
NOD2 Viral ssRNA (−)ssRNA viruses
NLRP3 dsRNA, bacterial RNA (−)ssRNA viruses
LRRFIP1 dsRNA (−)ssRNA viruses, bacteria
of host PRRs and molecules involved in downstream signaling
pathways. Thus, many pathogens code for proteins that lower cel-
lular levels of PRRs and signaling molecules or directly disrupt
their antimicrobial activities [reviewed in Ref. (79, 100)]. Other
strategies are discussed below.
RNA EDITING
Some (−)ssRNA viruses edit the 5′-ppp moieties in their genomes
as well as replication intermediates into 5′ mono-phosphates to
avoid recognition by RLRs (101). Arenaviruses produce RNA pan-
handle structures with a 5′-ppp containing a GTP overhanging
nucleotide. This viral structure is suggested to act as a RIG-I
ligand decoy, by trapping RIG-I but not activating it (102). We
are beginning to understand how eukaryotic cells use nucleoside
modifications in order to protect self-RNAs from innate sensing.
For example, higher eukaryotes have acquired the ability to 2′-O-
methylate their mRNAs, allowing cellular receptors to distinguish
self from unmethylated non-self mRNA through specific types of
antiviral sensors such as MDA5 and IFITs (57, 85). Consistent with
the red queen hypothesis (103), which postulates that parasites
have to constantly evolve in order to adapt to their host species,
the same immune escape strategy has been mimicked by several
pathogens, like flaviviruses (84, 86). Similarly, 2′-O-methylation
of G18 (Gm18) on bacterial tRNA suppresses activation of the
immune response in plasmacytoid DCs (104, 105).
COMPARTMENTALIZATION IN THE CYTOPLASM
Flaviviruses and other viruses are also known to induce cellu-
lar membrane reorganization that allows them to replicate in
subcellular compartments, creating new replication-dependent
organelles (106). Thus, tick-borne encephalitis virus or Japan-
ese encephalitis virus have been shown to rearrange endoplas-
mic reticulum membranes to provide a compartment where viral
dsRNA is concealed from PRR recognition. This hijacking of inter-
nal cell membrane induces a delayed cytosolic exposure of viral
RNA to innate receptors and accordingly, IFN-I responses are only
measured late in the replication cycle (107–109).
PROTECTING OR DEGRADING LIGANDS
The NS1 protein from influenza virus can prevent RNA sensing
through the formation of a chain of NS1 molecules along the
influenza dsRNA backbone (110). Picornaviruses mask their 5′-
ppp with a viral encoded protein, VPg, which functions as a 5′
cap and as a primer during RNA synthesis. Interestingly, studies
have shown that VPg could be used to evade RIG-I recognition
(111). Similarly, Ebola virus VP35 assembles into dimmers to cap
the ends of viral dsRNA and hide the specific RIG-I recognition
site (112). While one VP35 monomer binds the terminus and
backbone of dsRNA, the other VP35 monomer binds only the
phosphate backbone of the dsRNA, displaying a unique mode of
dsRNA concealing from PRR (112). Another hemorrhagic fever
virus, Lassa fever virus, uses the 3’–5’ exonuclease activity of its
nucleoprotein (NP) to degrade stimulatory dsRNA (113). This
activity seems to be shared by other arenaviruses (114). Finally,
the protein C from human parainfluenza virus type 1 (HPIV1),
a paramyxoviridae, has been shown to limit the accumulation of
dsRNA. Cell infection by a virus mutant defective for the C protein
displays higher accumulation of several viral RNAs, including viral
genome, antigenome, and mRNA, eventually leading to the accu-
mulation of dsRNA. Thus, by limiting intracytosolic quantities of
viral dsRNA, the C protein of HPIV1 avoids dsRNA triggering of
MDA5 and PKR in infected cells (115).
CONCLUDING REMARKS
The multiplicity of PRR pathways is an essential determinant of
the immune system’s ability to sense with precision the level of
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microbial threat and to respond accordingly (4). However, as far
as cytosolic RNA sensors are concerned, it is striking to observe the
contrast between the high number of PRRs that have been isolated
and the similarities of the PAMPs they recognize (Table 1). While
5′-ppp and dsRNA are undoubtedly powerful triggers of the innate
immunity, they cannot account for the diversity of responses that
the organism is able to elicit against a wide range of pathogens. Our
understanding of how the immune system distinguishes between
foreign and self-nucleic acids will continue to improve over time.
This will help us better define the precise role played by cytosolic
RNA sensors in the global immune response against pathogens.
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